A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)

NCT07709000 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Lymphocytic Leukaemia
Small Lymphocytic Lymphoma
Hematologic Malignancies

Interventions

BIOLOGICAL: MK-1045
DRUG: Acetaminophen (or similar antipyretic)
DRUG: Diphenhydramine (or similar antihistamine)
DRUG: Dexamethasone
BIOLOGICAL: Tocilizumab
BIOLOGICAL: Tocilizumab biosimilar
BIOLOGICAL: Siltuximab

Sponsor

Merck Sharp & Dohme LLC